197 related articles for article (PubMed ID: 20726902)
1. Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.
Rudin C; Spaenhauer A; Keiser O; Rickenbach M; Kind C; Aebi-Popp K; Brinkhof MW; ;
HIV Med; 2011 Apr; 12(4):228-35. PubMed ID: 20726902
[TBL] [Abstract][Full Text] [Related]
2. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
3. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
[TBL] [Abstract][Full Text] [Related]
4. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Short CE; Douglas M; Smith JH; Taylor GP
HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
Kourtis AP
J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
[No Abstract] [Full Text] [Related]
6. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital.
Asavapiriyanont S; Kasiwat S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S66-70. PubMed ID: 21717881
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
9. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
[TBL] [Abstract][Full Text] [Related]
10. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
[No Abstract] [Full Text] [Related]
11. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
Buchholz B; ;
Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
[No Abstract] [Full Text] [Related]
12. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
13. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
14. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
Kourtis AP; Schmid CH; Jamieson DJ; Lau J
AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
[TBL] [Abstract][Full Text] [Related]
15. Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART.
Lopez M; Figueras F; Hernandez S; Lonca M; Garcia R; Palacio M; Coll O
AIDS; 2012 Jan; 26(1):37-43. PubMed ID: 22008651
[TBL] [Abstract][Full Text] [Related]
16. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
Martin F; Taylor GP
J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
[TBL] [Abstract][Full Text] [Related]
17. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.
Hawkins D; Blott M; Clayden P; de Ruiter A; Foster G; Gilling-Smith C; Gosrani B; Lyall H; Mercey D; Newell ML; O'Shea S; Smith R; Sunderland J; Wood C; Taylor G;
HIV Med; 2005 Jul; 6 Suppl 2():107-48. PubMed ID: 16033339
[No Abstract] [Full Text] [Related]
19. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
[TBL] [Abstract][Full Text] [Related]
20. Update on antiretroviral therapy.
Riordan A; Bugembe T
Arch Dis Child; 2009 Jan; 94(1):70-4. PubMed ID: 18838416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
